A new technique for gene sequencing has produced the most complete human genome ever assembled with a single technology - the nanapore, developed by UK company Oxford Nanopore Technologies.

A new pan-European network will integrate long-read sequencing into clinical practice, improving diagnosis of rare diseases ...

After a serious stock market slump, the boss of this FTSE 250 biotech company has reportedly highlighted its takeover exposure. The post Down 83%! This FTSE 250 firm could now be a stock market ...

Oxford Nanopore Technologies (LSE: ONT) stock was the biggest riser in the FTSE 250 index yesterday (13 January). Shares of ...

CariGenetics, in collaboration with Oxford Nanopore Technologies, has “launched its Caribbean Genome Programme, the first ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. The boss of the UK biotech seen as a beacon of hope for the London IPO market only four years ago has ...

The genetic sequencing market could grow to $75 billion by 2033. Illumina ranks as the largest player in genetic sequencing. Other top genetic sequencing companies include PacBio, 10X Genomics ...

Understanding of genetic factors that influence prostate cancer and other conditions is expected to improve thanks to a ...

LONDON - Oxford Nanopore Technologies plc has announced that their Chief Financial Officer, Nick Keher, has engaged in a transaction under the company’s Share Incentive Plan (SIP) on March 12, 2025.